Anticancer agent 380
Anticancer agent 380 is an anticancer agent that induces PANoptosis. Anticancer agent 380 increases the expression of the pyroptosis-related inflammasome sensor NLRP3, the BAX/BCL2 expression ratio, the cleavage and activation of caspase-3, the generation of the GSDME N-terminal fragment, and the phosphorylation of MLKL. Anticancer agent 380 induces G2/M cell cycle arrest and inhibits colony formation and cell migration. Anticancer agent 380 is a dual-responsive fluorescent probe for pH and viscosity and can be used for intracellular imaging. Anticancer agent 380 can be used for research on hepatocellular carcinoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2988881-33-8
- 分子式: C24H21N3O2
- 分子量:383.44
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Caspase アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
NLRP3 |
Bax |
BCL2 |
Caspase 3 |
GSDME |
MLKL |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
7.18 μM
|
Cytotoxicity against human HepG2 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against human HepG2 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
| SMMC-7721 | IC50 |
14.08 μM
|
Cytotoxicity against human SMMC-7721 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against human SMMC-7721 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
| Bel-7402 | IC50 |
9.24 μM
|
Cytotoxicity against human Bel-7402 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against human Bel-7402 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
| HSC-T6 | IC50 |
11.39 μM
|
Cytotoxicity against HSC-T6 cells assessed as viability reduction incubated 48 hrs by MTS assay.
Cytotoxicity against HSC-T6 cells assessed as viability reduction incubated 48 hrs by MTS assay.
|
42700738 |
体外実験
Anticancer agent 380 (5-20 µM; 24 h) inhibits colony formation in HepG2 and Bel-7402 hepatocellular carcinoma cells in a concentration-dependent manner[1].
Anticancer agent 380 (5-20 µM; 48 h) inhibits the migration of HepG2 and Bel-7402 hepatocellular carcinoma cells in a concentration-dependent manner[1].
Anticancer agent 380 (5-20 µM; 48 h) induces apoptosis in HepG2 cells, with total apoptotic cells reaching 19.75% at 20 µM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2 and Bel-7402 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:24 h
-
Result:Inhibited colony formation in HepG2 and Bel-7402 hepatocellular carcinoma cells in a concentration-dependent manner.
-
Cell Line:HepG2 and Bel-7402 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:48 h
-
Result:Cell migration was inhibited in both HepG2 and Bel-7402 cells, with increased wound width and reduced healing rate at 5, 10, and 20 µM compared with the control.
-
Cell Line:HepG2 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:48 h
-
Result:Induced G2/M cell cycle arrest in HepG2 cells.
-
Cell Line:HepG2 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:24 h
-
Result:With increasing concentration from 5 µM to 20 µM, blue fluorescence was enhanced and the number of apoptotic cells increased.
The total apoptotic cell proportion increased to 19.75% at 20 µM.
-
Cell Line:HepG2 cells
-
Concentration:5, 10, 20 µM
-
Incubation Time:48 h
-
Result:BCL2 decreased and BAX increased, increasing the BAX/BCL2 ratio.
Cleaved caspase-3 increased, GSDME was cleaved to GSDME-N, NLRP3 increased, and MLKL phosphorylation increased in a concentration-dependent manner.
- RNA extraction experimental
- Western Blot
- Scratch/Wound-Healing Migration Assay
- BrdU Incorporation Assay
- Cell migration
- Neural Crest/Neuronal Cell Migration Explant Assay
- Protocol for Cell Cycle
- Liver Cancer Modeling
- Colony Formation (Clonogenic) Assay
- Kinase activity and phosphorylation assays
- Flow cytometric DNA-content cell-cycle staining
- Zigmond Chamber Chemotaxis Assay
- Under-Agarose Cell Migration Assay
- Transwell/Boyden Chamber Migration Assay
- Apoptosis Solutions
- 3D Collagen/Hydrogel Matrix Migration Assay
- Protocol for Kinase activity and phosphorylation assays
- Soft Agar Colony Formation Assay
- Cell-Exclusion Zone Migration Assay
- Dunn/Insall Chamber Chemotaxis Assay
- Pyroptosis Solutions
化学情報
-
CAS 番号 2988881-33-8
-
分子量 383.44
-
分子式 C24H21N3O2
-
SMILES
O=C(C1=CC=C2NC(C3=CC4=C(C=C3)N(CC)C5=C4C=CC=C5)=NC2=C1)OCC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Anticancer agent 380
- 2988881-33-8
- Anticancer agent380
- Anticancer agent-380
- NOD-like Receptor (NLR)
- Bcl-2 Family
- Caspase
- Mixed Lineage Kinase
- PANoptosis
- Pyroptosis
- MLKs
- G2/M cell cycle arrest
- GSDME
- MLKL phosphorylation
- NLRP3 inflammasome
- apoptosis
- hepatocellular carcinoma
- necroptosis
- pyroptosis
- reactive oxygen species
- Inhibitor
- inhibitor
- inhibit